Wellgistics Health Files 8-K on Equity Sales

Ticker: WGRX · Form: 8-K · Filed: Mar 27, 2025 · CIK: 2030763

Sentiment: neutral

Topics: unregistered-securities, corporate-action

TL;DR

Wellgistics Health sold unregistered equity, filing 8-K on 3/27.

AI Summary

Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on March 27, 2025, reporting unregistered sales of equity securities and a Regulation FD disclosure. The filing date for the report is March 21, 2025. The company is incorporated in Delaware and headquartered in Tampa, Florida.

Why It Matters

This filing indicates potential dilution or changes in ownership structure due to unregistered equity sales, which could impact existing shareholders.

Risk Assessment

Risk Level: medium — Unregistered sales of equity can sometimes signal financial distress or a need for capital, potentially impacting stock value.

Key Players & Entities

FAQ

What type of equity securities were sold unregistered?

The filing does not specify the type of equity securities sold unregistered, only that such sales occurred.

What is the reason for the unregistered sale of equity securities?

The filing does not disclose the specific reason for the unregistered sale of equity securities.

When was the company formerly known as Danam Health, Inc.?

The company's name change from Danam Health, Inc. to Wellgistics Health, Inc. occurred on July 17, 2024.

What is the SIC code for Wellgistics Health, Inc.?

The Standard Industrial Classification (SIC) code for Wellgistics Health, Inc. is 5122, which corresponds to WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES.

What is the company's principal executive office address?

The company's principal executive office is located at 3000 Bayport Drive Suite 950, Tampa, FL 33607.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding Wellgistics Health, Inc. (WGRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing